HCT Core Topics Connection: Chimeric Antigen Receptor (CAR) T-cell Therapies

This module will summarize the mechanism of action and manufacturing process of CAR T-cells, evaluate data supporting the use of the FDA-approved CART T-cell products, and discuss the presentation and management of CAR T-cell toxicities. 

Presented by:

Katie S. Gatwood, PharmD, BCOP – Vanderbilt University Medical Center

May T. Aziz, PharmD, BCOP – Virginia Commonwealth University Health System


Key:

Complete
Failed
Available
Locked
Module Recording
Open to view video.
Open to view video. This module will focus on Chimeric Antigen Receptor (CAR) T-cell Therapies. It is presented by Katie S. Gatwood, PharmD, BCOP and May T. Aziz, PharmD, BCOP.
Slides
Open to download resource.
Open to download resource.
Module Quiz
10 Questions  |  4 attempts  |  8/10 points to pass
10 Questions  |  4 attempts  |  8/10 points to pass
Evaluation
6 Questions
Certificate of Completion
No credits available  |  Certificate available
No credits available  |  Certificate available